Search

John S. Kenyon

Examiner (ID: 168, Phone: (571)270-1567 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1625, 1622
Total Applications
1220
Issued Applications
838
Pending Applications
151
Abandoned Applications
270

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16204685 [patent_doc_number] => 20200237675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => Systems and Methods for Increasing Stability of Dronabinol Compositions [patent_app_type] => utility [patent_app_number] => 16/827079 [patent_app_country] => US [patent_app_date] => 2020-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5568 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827079 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/827079
Systems and methods for increasing stability of dronabinol compositions Mar 22, 2020 Issued
Array ( [id] => 16268732 [patent_doc_number] => 20200270219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => CRYSTALLINE FORMS OF (S)-AFOXOLANER [patent_app_type] => utility [patent_app_number] => 16/825616 [patent_app_country] => US [patent_app_date] => 2020-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825616 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/825616
Crystalline forms of ( Mar 19, 2020 Issued
Array ( [id] => 17805018 [patent_doc_number] => 20220256853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => PLANT CULTIVATION METHOD [patent_app_type] => utility [patent_app_number] => 17/441453 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/441453
PLANT CULTIVATION METHOD Mar 17, 2020 Pending
Array ( [id] => 16176843 [patent_doc_number] => 20200223811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT [patent_app_type] => utility [patent_app_number] => 16/818645 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9133 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818645 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/818645
PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT Mar 12, 2020 Abandoned
Array ( [id] => 16111487 [patent_doc_number] => 20200207766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-02 [patent_title] => INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/817109 [patent_app_country] => US [patent_app_date] => 2020-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30171 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817109 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/817109
Inhibitors of KRAS G12C and methods of using the same Mar 11, 2020 Issued
Array ( [id] => 17595251 [patent_doc_number] => 20220144824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHOD FOR PREPARING TRICYCLIC COMPOUND, AND INTERMEDIATE THEREOF [patent_app_type] => utility [patent_app_number] => 17/435181 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435181 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/435181
METHOD FOR PREPARING TRICYCLIC COMPOUND, AND INTERMEDIATE THEREOF Mar 1, 2020 Abandoned
Array ( [id] => 16086785 [patent_doc_number] => 20200197379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS [patent_app_type] => utility [patent_app_number] => 16/805381 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11114 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805381 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/805381
Composition for preventing or treating atopic dermatitis Feb 27, 2020 Issued
Array ( [id] => 16253490 [patent_doc_number] => 20200262864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/795356 [patent_app_country] => US [patent_app_date] => 2020-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795356 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/795356
DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME Feb 18, 2020 Abandoned
Array ( [id] => 16252083 [patent_doc_number] => 20200261457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile [patent_app_type] => utility [patent_app_number] => 16/789976 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789976 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/789976
Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile Feb 12, 2020 Issued
Array ( [id] => 16236688 [patent_doc_number] => 20200253922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => METHODS FOR NON-IRRITATING PULMONARY ADMINISTRATION OF CANNABINOIDS USING SOFT MIST INHALERS [patent_app_type] => utility [patent_app_number] => 16/788507 [patent_app_country] => US [patent_app_date] => 2020-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788507 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/788507
METHODS FOR NON-IRRITATING PULMONARY ADMINISTRATION OF CANNABINOIDS USING SOFT MIST INHALERS Feb 11, 2020 Abandoned
Array ( [id] => 16221240 [patent_doc_number] => 20200246356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/782406 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11171 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782406 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/782406
Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions Feb 4, 2020 Issued
Array ( [id] => 16206491 [patent_doc_number] => 20200239481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => Synthetic Process and Novel Intermediates [patent_app_type] => utility [patent_app_number] => 16/775451 [patent_app_country] => US [patent_app_date] => 2020-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775451 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/775451
Synthetic process and intermediates Jan 28, 2020 Issued
Array ( [id] => 19717311 [patent_doc_number] => 12202834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-21 [patent_title] => Solid state forms of oclacitinib maleate [patent_app_type] => utility [patent_app_number] => 17/426931 [patent_app_country] => US [patent_app_date] => 2020-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 6842 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426931 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426931
Solid state forms of oclacitinib maleate Jan 28, 2020 Issued
Array ( [id] => 16397206 [patent_doc_number] => 20200338064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => HIGH CONCENTRATION LOCAL ANESTHETIC FORMULATIONS [patent_app_type] => utility [patent_app_number] => 16/774490 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774490 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/774490
HIGH CONCENTRATION LOCAL ANESTHETIC FORMULATIONS Jan 27, 2020 Abandoned
Array ( [id] => 16204798 [patent_doc_number] => 20200237788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => PROCESS FOR PREPARING INJECTABLE FOSAPREPITANT DIMEGLUMINE COMPOSITIONS HAVING IMPROVED STORAGE STABILITY [patent_app_type] => utility [patent_app_number] => 16/774760 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774760 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/774760
Process for preparing injectable Fosaprepitant Dimeglumine compositions having improved storage stability Jan 27, 2020 Issued
Array ( [id] => 15927741 [patent_doc_number] => 20200155504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => COMPOSITIONS COMPRISING UROLITHINS AND USES THEREOF FOR THE STIMULATION OF INSULIN SECRETION [patent_app_type] => utility [patent_app_number] => 16/751677 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10549 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751677 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/751677
Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion Jan 23, 2020 Issued
Array ( [id] => 17292153 [patent_doc_number] => 20210387992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => POLYMORPH FORM OF A MONOPHOSPHATE HYDRATE SALT OF A KNOWN TETRAHYDROISOQUINOLINE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/424721 [patent_app_country] => US [patent_app_date] => 2020-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424721 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/424721
POLYMORPH FORM OF A MONOPHOSPHATE HYDRATE SALT OF A KNOWN TETRAHYDROISOQUINOLINE DERIVATIVE Jan 19, 2020 Abandoned
Array ( [id] => 16176895 [patent_doc_number] => 20200223863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => SYNTHESIS OF HALICHONDRIN ANALOGS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/746233 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52353 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746233 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/746233
Synthesis of halichondrin analogs and uses thereof Jan 16, 2020 Issued
Array ( [id] => 16176846 [patent_doc_number] => 20200223814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => NOVEL METHODS AND RELATED TOOLS FOR CBD CONVERSION TO THC [patent_app_type] => utility [patent_app_number] => 16/741741 [patent_app_country] => US [patent_app_date] => 2020-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741741 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/741741
Methods and related tools for CBD conversion to THC Jan 12, 2020 Issued
Array ( [id] => 17505068 [patent_doc_number] => 20220098170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => PROCESS FOR THE SYNTHESIS OF GEPIRONE [patent_app_type] => utility [patent_app_number] => 17/422865 [patent_app_country] => US [patent_app_date] => 2020-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422865 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422865
PROCESS FOR THE SYNTHESIS OF GEPIRONE Jan 12, 2020 Abandoned
Menu